Mobile Phone Radiation: French Agency Urges Continued Monitoring, Prudent Use
Paris, France – A recent assessment by the French Agency for Food, Environmental and Occupational health & Safety (ANSES) confirms that current exposure levels to radiofrequency electromagnetic fields emitted by mobile phones remain below regulatory limits, but warrants ongoing vigilance due to evolving usage patterns and potential long-term effects. The agency’s findings, released today, come as mobile phone use continues to rise globally, particularly among children, prompting renewed discussion about potential health risks.
While not indicating an immediate health crisis, ANSES emphasizes the need for continued research and recommends adopting “digital hygiene” practices to minimize exposure. The report revisits concerns stemming from a 2011 classification by the International Agency for Research on Cancer (IARC),a WHO-affiliated body,which categorized radiofrequency electromagnetic fields as “possibly carcinogenic to humans” – a designation based on limited,but not conclusive,scientific data at the time. This classification triggered ongoing monitoring and research efforts worldwide.
ANSES does not advocate for alarm or complete disconnection from mobile technology. Rather, the agency suggests simple steps to reduce exposure, including utilizing hands-free kits or loudspeakers during calls, avoiding use in areas with poor reception where devices operate at maximum power, and limiting prolonged calls for children, whose developing bodies might potentially be more vulnerable. Periodically putting smartphones aside, even briefly, is also encouraged.
The agency’s assessment underscores the importance of adapting to changing mobile phone usage and prioritizing the health of younger generations as they navigate an increasingly digital world. Further studies are planned to track exposure levels and assess potential health impacts as technology evolves.
According to the IARC,the “possibly carcinogenic” classification (Group 2B) doesn’t establish a definitive risk,but acknowledges the need for continued monitoring given the limitations of available scientific evidence.
